From: Effectiveness of an antimicrobial treatment scheme in a confined glanders outbreak
Treatment period (n = 23) | Post treatment observation period (n = 17) | ||||
---|---|---|---|---|---|
Parameters | d 0 | d 84 | d 180 | d 240 | d 360 |
RBC count (1012/1) | 3.94 ± 0.78 | 6.30 ± 0.4 | 6.80 ± 0.37 | 7.053 ± 0.29 | 6.957 ± 0.36 |
WBC count (109/1) | 19.15 ± 4.11 | 8.10 ± 0.79 | 7.91 ± 1.23 | 7.97 ± 2.14 | 7.52 ± 1.12 |
Hb [g/dL] | 7.918 ± 1.7 | 11.94 ± 0.69 | 12.79 ± 1.1 | 13.58 ± 1.0 | 13.13 ± 1.2 |
PCV (ratio) | 0.25 ± 0.047 | 0.38 ± 0.015 | 0.41 ± 0.028 | 0.39 ± 0.025 | 0.38 ± 0.0 12 |
ESR (mm/20 min) | 126.83 ± 10.40 | 25.15 ± 2.6 | 21.42 ± 1.94 | 23.19 ± 2.41 | 19.89 ± 3.15 |
Differential Leukocyte Count | |||||
Neutrophils (%) | 73.06 ± 9.12 | 51.0 ± 9.12 | 50.3 ± 4.39 | 53.2 ± 3.14 | 57.28 ± 0.89 |
Lymphocytes (%) | 21.69 ± 6.95 | 39.7 ± 3.91 | 47.1 ± 3.01 | 43.01 ± 2.10 | 37.5 ± 1.23 |
Eosinophils (%) | 4.77 ± 2.16 | 3.11 ± 0.57 | 2.12 ± 0.76 | 2.190 ± 0.911 | 4.23 ± 2.11 |
Monocytes (%) | 1.69 ± 1.02 | 1.52 ± 0.89 | 1.76 ± 1.40 | 2.140 ± 1.024 | 1.2 ± 1.00 |
Basophils (%) | - | - | - | - | - |